Empatía, agresividad y perdón en contextos de vulnerabilidad, hostilidad y seguridad en niños y adolescentes

Introducción: El objetivo de este artículo fue identificar las variables que mejor predicen las medidas de agresión, empatía y perdón, como también las principales diferencias en contextos vulnerables, hostiles y seguros, en una muestra de niños, niñas y adolescentes pertenecientes a una población vulnerable. Método: se realizó un estudio cuantitativo transversal con una muestra no probabilística incidental de 85 participantes, se emplearon medidas psicométricas para la empatía, agresión y perdón. Los participantes fueron convocados en una fundación de atención a víctimas para realizar una entrevista y aplicar el test. Resultados: Se encontraron efectos estadísticamente significativos entre las variables del modelo verificado, donde la empatía predice la agresión en el contexto hostil, pero no en el vulnerable y seguro. A su vez, la empatía predice el perdón en los contextos vulnerables y seguros, y la agresión predice el perdón en el modelo hostil, pero no es significativo su efecto en el contexto vulnerable y seguro. Además, la empatía tiene un papel clave en la comprensión del perdón, dado que se asocia a conductas agresivas en los contextos de hostilidad, mientras que un modelo de perdón debería ser diferencial en estos contextos. Conclusiones: Los hallazgos de este estudio brindan evidencia empírica que sustenta la importancia de la implementación de estrategias para mejorar las habilidades relacionadas con la empatía en niños y adolescentes, desde la perspectiva de la educación para la paz y el perdón. Además, se demostró que los aspectos como el clima familiar, las vulnerabilidades de los contextos de riesgo y la misma cultura, pueden determinar el desarrollo de habilidades socioemocionales que favorecen el perdón, empatía y otras capacidades interpersonales.

Introduction: The aim of this study was to identify the variables that best predict measures of aggression, empathy, and forgiveness, as well as the main differences in vulnerable, hostile and safe contexts, in a sample of children and adolescents belonging to a vulnerable population. Method: A cross-sectional quantitative study was conducted with a non-probabilistic incidental sample of 85 participants. Psychometric measures of empathy, aggression, and forgiveness were used. The participants were invited to a victim assistance foundation for an interview and test application. Results: Statistically significant effects were found among the variables in the verified model, where empathy predicts aggression in the hostile context, but not in the vulnerable and safe context. In turn, empathy predicts forgiveness in the vulnerable and safe contexts, and aggression predicts forgiveness in the hostile model, but its effect in the vulnerable and safe context is not significant. Furthermore, empathy plays a key role in understanding forgiveness, given that it is associated with aggressive behaviors in the hostile contexts, whereas a forgiveness model should be differential in these contexts. Conclusions: The findings of this study provide empirical evidence that supports the importance of implementing strategies to improve empathy-related skills in children and adolescents, from the perspective of peace education and forgiveness. In addition, it was shown that aspects such as family climate, vulnerabilities of risk contexts and culture itself, can determine the development of socioemotional skills that favor forgiveness, empathy, and other interpersonal skills.

Ibogaína: un psicodélico atípico con potencial antiadictivo / Ibogaine: an atypical psychedelic with anti-addictive potential

El trastorno por uso de sustancias es una enfermedad crónica de graves consecuencias. Actualmente, los tratamientos farmacológicos no apuntan a corregir los cambios neurobiológicos generados en el cerebro por el uso crónico de sustancias de abuso, sino que se enfocan principalmente en la atenuación de algunos de los síntomas que padece el consumidor. La ibogaína es un psicodélico atípico que, tanto en estudios observacionales como en ensayos clínicos abiertos, ha mostrado una propiedad antiadictiva que perdura en el tiempo. Sin embargo, su delicado perfil de toxicidad cardíaca, así como su uso en entornos sin adecuadas medidas de seguridad, han limitado su progresión en las investigaciones clínicas. Los efectos antiadictivos de ibogaína han disparado diversas líneas de investigación básica, preclínica y clínica, que buscan confirmar su efectividad, entender sus mecanismos de acción y delimitar su perfil de seguridad. Dada la poca información disponible para los profesionales de salud sobre esta sustancia, esta revisión busca aportar información acerca de su potencial terapéutico, posibles mecanismos de acción y riesgos asociados a su administración.

Substance use disorder is a chronic disease with severe consequences. Currently, pharmacological treatments do not aim to correct the neurobiological changes generated in the brain by the chronic use of substances of abuse, but rather focus mainly on attenuating some of the user's symptoms. Ibogaine is an atypical psychedelic that has shown long-lasting and interesting antiaddictive properties in both observational studies and open-label clinical trials. However, its delicate profile of cardiac toxicity, as well as its use in settings without adequate safety measures, have limited its progression in clinical research. The anti-addictive effects of ibogaine have triggered diverse scientific research in basic, preclinical, and clinical areas, which seek efficacy confirmation and to fully understand ibogaine´s underlying mechanisms of action and its safety profile. Given that there is little information available to health professionals about ibogaine and its antiaddictive properties, this review aims to provide published data about its therapeutic potential in drug addiction, its mechanisms of action, and risks associated with its administration.

Effect of Mid-Term Dietary Administration of the Caesalpinia coriaria Extract on the Sustainable Mitigation of Equine Fecal Methane, Carbon Monoxide and Hydrogen Sulfide Production.

This study aimed to evaluate the dietary administration of the Caesalpinia coriaria (CC) extract for 30 days on in vitro fecal greenhouse gases production. Fecal samples, as inoculums, were collected from horses given daily 0- (Fecal 0), 60- (Fecal 60) and 120- (Fecal 60) mL CC aqueous extract per animal. The extract dose was mixed with the morning feeding diet at 6:00 h for each horse. During incubation, 0-, 0.6-, 1.2- and 1.8-mL CC extracts were added to the basal diet which was fed to horses (as subtract) and evaluated with each fecal type. Feces from the horses given no CC extract produced the lowest (P = .0014) methane while the fecal from horses given CC produced more methane . It was also observed that all CC doses linearly (P = .0457) produced more methane than the control. Furthermore, Fecal 0 was more efficient and produced less methane for every unit of metabolizable energy, organic matter, and short chain fatty acids while Fecal 60 was the least efficient. Production of H2S showed that feces of equine orally give 60 mL/day CC produced the highest while Fecal 0 and Fecal 120 were similar. Fecal type x dose showed that 0 mL/g DM produced the highest H2S while 1.8 mL/g DM produced the lowest. Thus, based on gas production, H2S, CO and CH4, feeding horses with 60 mL/day of CC with or without 0.6 mL/g DM of CC extract is recommended for the sustainable mitigation of greenhouse gases emission in horses.

Bronchopulmonary dysplasia as a risk factor for asthma in school children and adolescents: A systematic review.

BACKGROUND: Bronchopulmonary dysplasia (BPD) is a chronic lung disease that mainly affects extremely pre-term infants, and remains the most common complication of prematurity. Several studies have shown that prematurity predisposes to the development of asthma in school children and adolescents. Nevertheless, it is not clear to what extent a history of BPD involves an additional risk. METHODS: A systematic review of studies assessing the association between BPD and asthma in school-children and adolescents was made. A literature search was carried out in the MEDLINE and EMBASE databases to retrieve articles published between 1 January 2000 and 31 August 2016. RESULTS: A total of 17 studies comprising 7433 patients were included in the review. There was considerable heterogeneity in the definitions of BPD and asthma among studies. Overall, the prevalence of asthma was higher in children and adolescents with a history of prematurity and BPD compared with those who did not develop BPD. However, in only one of the studies did this difference reach statistical significance. The main limitation of this review was potential bias due to the lack of adjustment for confounding factors between exposure (BPD) and outcome (asthma) in most of the studies. CONCLUSION: Based on the studies reviewed, it cannot be argued that BPD, as an independent factor of prematurity, increases the risk of asthma defined by clinical parameters in school-children and adolescents. Further studies of greater methodological quality and homogeneous diagnostic criteria of BPD and asthma are needed for improved assessment of this association.

[Guidelines for the follow up of patients with bronchopulmonary dysplasia]. / Protocolo de seguimiento de los pacientes con displasia broncopulmonar.

Bronchopulmonary dysplasia (BPD) is the most common complication of preterm birth, and remains a major problem in pediatric pulmonology units. The decision of discharging from the Neonatal Unit should be based on a thorough assessment of the condition of the patient and compliance with certain requirements, including respiratory and nutritional stability, and caregiver education on disease management. For proper control of the disease, a schedule of visits and complementary tests should be established prior to discharge, and guidelines for prevention of exacerbations and appropriate treatment should be applied. In this paper, the Working Group in Perinatal Respiratory Diseases of the Spanish Society of Pediatric Pulmonology proposes a protocol to serve as a reference for the follow up of patients with BPD among different centers and health care settings. Key factors to consider when planning discharge from the Neonatal Unit and during follow up are reviewed. Recommendations on treatment and prevention of complications are then discussed. The final section of this guide aims to provide a specific schedule for follow-up and diagnostic interventions to be performed in patients with BPD.

[Late-onset Group B Streptococcus disease in twins delivered by caesarean section]. / Infección tardía por estreptococo grupo B en gemelos nacidos mediante cesárea.

Group B Streptococcus (GBS) is a commensal pathogen of the gut microflora with a well-established role in the aetiology of early and late onset GBS infections in the newborn. The incidence of early onset infections by vertical transmission has been drastically reduced in recent decades with the use of intravenous intrapartum prophylaxis. Progress in risk factor detection and prophylaxis of late-onset infection has however remained static. The ongoing modifications and improvements of the guidelines regarding prophylaxis, risk factors and prevention of the early-onset GBS disease have not addressed late-onset GBS infection in detail. The following cases illustrate the presence of grey areas in current guidelines and in the knowledge of the pathogenesis of late-onset disease.

[Diagnostic value of exhaled nitric oxide measurement in mild asthma]. / Valor de la determinación de óxido nítrico exhalado en el diagnóstico de asma episódica.

OBJECTIVES: To assess the diagnostic value of fractional exhaled nitric oxide (FE(NO)) in mild asthma. MATERIAL AND METHODS: Cross-sectional descriptive study in a group of patients with no history of respiratory or allergic illness (control group) and a group of patients with a history of mild asthma with no baseline treatment (asthma group), both aged 6 to 14 years. The following examinations were performed: measurement of FE(NO) using the portable NIOX MINO(®) device, allergy tests and spirometry. Repeatability of paired FE(NO) measurements was estimated with the intraclass correlation coefficient, the repeatability coefficient and the variation coefficient. The diagnostic value was assessed with the sensitivity, specificity, area under the ROC curve and positive likelihood ratio (LR+) for each cut-off point. RESULTS: Eighty-seven patients were included in the control group and 57 in the asthma group. The mean FE(NO) value was 12.1 ppb (SD 13.5) in the control group and 42.9 ppb (SD 24.5) in asthmatics (P<.001). The intraclass correlation coefficient was 0.98 (95% CI: 0.96-0.99) and of 0.97 (95% CI: 0.92-0.99) in controls and asthmatics, respectively. The repeatability coefficient was 5.5 in controls and 9.2 in asthmatic children, and the median variation coefficient was 8.3% and 6.1%. The optimal cut-off value for FE(NO) was 19 ppb (sensitivity and specificity were 91.4% and 87.2%, respectively). The area under the ROC curve was 0.93 (95% CI: 0.88-0.97) (P<.001) and the LR+ was 7.1. Subclinical sensitisation to pneumoallergens accounted for most false positive cases. CONCLUSIONS: The determination of FE(NO) with NIOX MINO(®) has an adequate repeatability, especially for healthy patients. For asthmatic patients we recommend determining the average of two measurements. The test has a high diagnostic value in mild asthma. Subclinical sensitisation to pneumoallergens can cause the FE(NO) value to rise to pathologic levels.

[Incidence of wheezing and associated risk factors in the first 6 months of life of a cohort in Valencia (Spain)]. / Incidencia y factores de riesgo de bronquitis sibilantes en los primeros 6 meses de vida en una cohorte de Alzira (Valencia).

OBJECTIVES: To determine the incidence of wheezing at 6 months of life in the town of Alzira (Valencia, Spain), and to analyse associated risk factors. METHODS: We included 636 newborns in a longitudinal birth cohort study between March 2007 and November 2008. Data were collected from hospital and primary care medical records and from questionnaires sent at 6 months post-natal. Bivariate and multivariate Cox regression analysis were performed to examine the risk factors associated with wheezing. RESULTS: At 6 months, 25.2% of infants had had 1 or more episodes of wheezing, whereas 5.6% had had 3 or more episodes. Emergency visits were reported in 11.6% of the infants, treatment with oral corticosteroids in 6.6% and admission to hospital in 4%. Independent risk factors for wheezing were male sex (relative risk [RR]: 2.1, 95% confidence interval [95% CI]: 1.5 to 2.9), younger gestational age (RR: 1.1, 95% CI: 1.0 to 1.2), season of birth between July and September (RR: 3.5, 95% CI: 2.0 to 5.9) and between October and December (RR: 2.0, 95% CI: 1.1 to 3.6), younger maternal age (RR: 1.0, 95% CI: 1.0 to 1.1), having siblings (RR: 3.1, 95% CI: 2.2 to 4.5), exposure to smoke (RR: 1.4, 95% CI: 12.0 to 2.0) and history of maternal asthma (RR: 1.7, 95% CI: 1.0 to 3.0). Breast feeding for at least 3 months (RR: 0.6, 95% CI: 0.4 to 0.8) and having immigrant parents (RR: 0.6, 95% CI: 0.4 to 0.9) were protective against wheezing. CONCLUSION: A high cumulative incidence of wheezing in the first 6 months of life was found in our population, in comparison with data reported in other cohort studies. Estimated risk factors were generally in accordance with those described by other authors. Having siblings and season of birth between July and September were the most important risk factors, reflecting the role of viral infections in the pathogenesis of wheezing in early childhood.

[Estimation of incidence and analysis of sepsis in an area of Valencia (Spain)]. / Incidencia estimada y análisis de la sepsis en un área de Valencia.

OBJECTIVES: To study the incidence of sepsis in an area of Valencia, as well as its characteristics, and to evaluate short-term outcomes. PATIENTS AND METHODS: An active surveillance program was carried out to determine the incidence and characteristics of sepsis. All patients attending the Hospital de La Ribera from January 1999 to December 2004 were included. Incidence rates were calculated and logistic regression analysis was performed. RESULTS: The incidence rate was 60.9 per 100,000 person-years. The incidence was highest among children younger than 1 year (1,138 per 100,000 person-years). A total of 14.4 % of cases were nosocomial infections. The most common microorganisms found were Escherichia coli, Streptococcus pneumoniae and Neisseria meningitidis. Microbiologically undocumented sepsis accounted for 32 % of the cases. The case-fatality rate was 1.3 %. Seventeen patients (11.1 %) were transferred to an intensive care unit (ICU). The risk of being transferred to an ICU was 14 times higher in patients with meningitis than in those with other sources of infection, independently of age and microbiological characteristics (OR 13.9, 95 % CI 2.6-75.3, P = 0.002). CONCLUSIONS: The incidence rate of sepsis is high in the pediatric age group. Clinical sepsis represented an important percentage of pediatric sepsis in our center. The main factor associated with patient transfer to the ICU was the central nervous system as the source of sepsis.